EQ-5D-3L at 6 months (mean) | EQ-5D-3L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-3L (95% CI) | Effect size (Cohen’s D)a | n | % reporting 3L score increase | |
---|---|---|---|---|---|---|
3L-VAS | ||||||
Improved | 0.82 | 0.84 | 0.02 (− 0.05 to 0.09) | 0.25 | 6 | 33 |
No change | 0.80 | 0.77 | − 0.02 (− 0.11 to 0.06) | − 0.12 | 32 | 25 |
Worsened | 0.80 | 0.77 | − 0.02 (0.10 to 0.04) | − 0.13 | 20 | 20 |
EQ-5D-5L at 6 months (mean) | EQ-5D-5L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-5L (95% CI) | Effect size (Cohen’s D) | n | % reporting 5L score increase | |
---|---|---|---|---|---|---|
5L-VAS | ||||||
Improved | 0.70 | 0.70 | 0.00 (− 0.15 to 0.15) | − 0.01 | 9 | 33 |
No change | 0.80 | 0.78 | − 0.02 (− 0.07 to 0.01) | − 0.17 | 29 | 41 |
Worsened | 0.78 | 0.74 | − 0.03 (− 0.12 to 0.05) | − 0.18 | 20 | 30 |